Natriuretic peptides in the diagnosis and management of heart failure

The natriuretic peptides are a family of related hormones that play a crucial role in cardiovascular homeostasis. They have recently emerged as potentially important clinical markers in heart failure. Recent data have suggested an important role for these markers in establishing the diagnosis of heart failure in patients with unexplained dyspnea in both acute care and ambulatory settings. Other clinical uses of the natriuretic peptides, such as screening for asymptomatic ventricular dysfunction, establishing prognosis or guiding titration of drug therapy, are under investigation but have not yet sufficiently been validated for widespread clinical use.

• Publication year

  2006

• Venue

  Canadian Medical Association Journal

• Publication date

  2006-09-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1503/cmaj.060236PMID 16966666PMCID PMC1559415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score.

  2006influential reference
• Competing interests: none declared.

  2006cited by this paper
• Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

  2006cited by this paper
• Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.

  2006cited by this paper
• NTproBNP‐guided drug treatment for chronic heart failure: design and methods in the “BATTLESCARRED” trial

  2006cited by this paper
• Accuracy of B‐type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: A systematic review

  2006cited by this paper
• Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP.

  2005cited by this paper
• Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

  2005cited by this paper
• How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

  2005cited by this paper
• Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study

  2005cited by this paper
• The N-Terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study

  2005cited by this paper
• Cardiac natriuretic peptides for cardiac health.

  2005cited by this paper
• Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study

  2005cited by this paper
• The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

  2005influential reference
• Pre‐discharge B‐type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit

  2005cited by this paper
• Does this dyspneic patient in the emergency department have congestive heart failure?

  2005cited by this paper
• Refining clinical diagnosis with likelihood ratios.

  2005cited by this paper
• Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

  2004cited by this paper
• Obesity and suppressed B-type natriuretic peptide levels in heart failure.

  2004cited by this paper
• A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure.

  2004influential reference
• Impact of Obesity on Plasma Natriuretic Peptide Levels

  2004cited by this paper
• Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic Dysfunction: A Community-Based Study

  2004cited by this paper
• Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.

  2003cited by this paper
• Prevention and management of chronic heart failure in management of asymptomatic patients.

  2003cited by this paper
• Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

  2003cited by this paper
• Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?

  2003cited by this paper
• Heart failure/transplant: abstractEffects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)☆

  2003cited by this paper
• B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.

  2003cited by this paper
• Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.

  2003cited by this paper
• Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart Failure

  2003cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

  2002cited by this paper
• B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure: Analysis From Breathing Not Properly (BNP) Multinational Study

  2002cited by this paper
• Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

  2002cited by this paper
• Effects of Valsartan on Circulating Brain Natriuretic Peptide and Norepinephrine in Symptomatic Chronic Heart Failure: The Valsartan Heart Failure Trial (Val-HeFT)

  2002cited by this paper
• Plasma brain natriuretic peptide concentration: impact of age and gender.

  2002cited by this paper
• A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.

  2001cited by this paper
• Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.

  2001cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.

  2001cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations

  2000cited by this paper
• Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.

  2000cited by this paper
• Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

  1997cited by this paper
• Plasma brain natriuretic peptide in assessment of acute dyspnoea.

  1994cited by this paper
• Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure

  1993cited by this paper
• Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure

  1993cited by this paper
• Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

  1993cited by this paper
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

  1991cited by this paper
• Harrison's Principles of Internal Medicine

  1988cited by this paper
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

  1981cited by this paper
• Decision-Making in Clinical Medicine

  1970cited by this paper

• Blood pressure variability is associated with heart failure risk, elevated NT-proBNP, and elevated high-sensitivity troponin: the Multi-Ethnic Study of Atherosclerosis (MESA).

  2025cites this paper
• Adherence to guidelines for natriuretic peptide testing in heart failure: a nationwide survey of healthcare professionals in Vietnam

  2025cites this paper
• Dynamic Prediction for Hospital Readmission in Patients with Chronic Heart Failure

  2025cites this paper
• Association between left ventricular reverse remodelling and the B-type natriuretic peptide–cGMP cascade after anterior acute myocardial infarction

  2025cites this paper
• Fetal NT-proBNP Concentrations in Response to Maternal Anemia: A Study of Term Pregnancies

  2025cites this paper
• A Comprehensive and Integrarive Review on Advanced Diagnosis and Clinical Management of Left Ventricular Dysfunction

  2025cites this paper
• A Novel Wearable Device for Continuous Bioimpedance Monitoring in Congestive Heart Failure Patients

  2023cites this paper
• Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction

  2022cites this paper
• Impact of Percutaneous Transluminal Renal Angioplasty on Autonomic Nervous System and Natriuresis in Hypertensive Patients With Renal Artery Stenosis

  2022cites this paper
• MANEJO DEL EDEMA PULMONAR AGUDO CARDIOGÉNICO EN EL SERVICIO DE URGENCIA

  2022cites this paper
• Purification, characterization, and preliminary serial crystallography diffraction advances structure determination of full-length human particulate guanylyl cyclase A receptor

  2022cites this paper
• Alterations of Cardiac Protein Kinases in Cyclic Nucleotide-Dependent Signaling Pathways in Human Ischemic Heart Failure

  2022cites this paper
• A literature survey on the biomarkers of cardiovascular disease

  2021cites this paper
• Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis

  2021cites this paper
• NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease

  2021cites this paper
• Analytical evaluation of serum non–transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population

  2021cites this paper
• Inhibition of Mammalian Target of Rapamycin Attenuates Recurrent Seizures Associated Cardiac Damage in a Zebrafish Kindling Model of Chronic Epilepsy

  2021cites this paper
• Milrinone is better choice for controlled low central venous pressure during hepatectomy: A randomized, controlled trial comparing with nitroglycerin.

  2021cites this paper
• Water - A life-giving toxin - A nephrological oxymoron. Health consequences of water and sodium balance disorders. A review article.

  2021cites this paper
• Value of Speckle Tracking Echocardiography in the Detection of Left Ventricular Dysfunction in Heart Failure Patients with Preserved Ejection Fraction

  2020influential citation
• Pretransplant NT-proBNP, Dialysis Vintage, and Posttransplant Mortality in Kidney Transplant Recipients

  2020cites this paper
• Higher plasma NT-proBNP levels correlate with syndrome of inappropriate antidiuretic hormone and poor prognosis in neurological patients

  2020cites this paper
• Can serum level of N‐terminal pro B‐type natriuretic peptide be used in patients with psoriasis as a predictor of cardiovascular disease?

  2019cites this paper
• Factors determining exercise capacity evaluated during cardiopulmonary exercise testing in 6‐month follow‐up after ST elevation myocardial infarction

  2019cites this paper
• Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms

  2019cites this paper
• Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction

  2019cites this paper
• Bedeutung des NT-proBNP in der Evaluation der diastolischen Dysfunktion bei Typ-2-Diabetikern

  2019influential citation
• Novel heart failure biomarkers: why do we fail to exploit their potential?

  2018cites this paper
• Summary Review: Elevated BNP levels in ME/CFS associate with cardiac dysfunction

  2018cites this paper
• Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.

  2018influential citation
• DIAGNOSTIC VALUE OF SERUM N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE FOR LEFT VENTRICULAR DYSFUNCTION IN HYPERTENSIVE CASES

  2017cites this paper
• Usefulness of Transthoracic Echocardiography Parameters and Brain Natriuretic Peptide as Mortality Predictors in Hospitalized Acutely Poisoned Patients: A Prospective Observational Study

  2017cites this paper
• Characterization of an 18F-Growth Hormone Secretagogue Probe for Positron Emission Tomography Imaging of the Growth Hormone Secretagogue Receptor

  2017cites this paper
• Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

  2017cites this paper
• Body Composition and Inflammation in Hemodialysis Patients

  2017cites this paper
• [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].

  2016cites this paper
• B‐type natriuretic peptide‐guided treatment for heart failure

  2016cites this paper
• Measurement of Biomarkers Troponin I, NT Pro BNP and ANP Between Horses with Signs of Respiratory Disease and Apparently Healthy Group

  2016cites this paper
• systolic time intervals combined with Valsalva maneuver for the diagnosis of left ventricular dysfunction in COPD exacerbations

  2016cites this paper
• Systolic time intervals combined with Valsalva maneuver for the diagnosis of left ventricular dysfunction in COPD exacerbations

  2016cites this paper
• Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome

  2016cites this paper
• Serum levels of N-terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis.

  2016cites this paper
• B-Type natriuretic peptide in the management of older persons with heart failure.

  2016cites this paper
• Hormonal adaptation to acute and chronic hypoxia : the role of brain natriuretic peptide and stress hormones in the diagnosis and etiology of altitude illness

  2016cites this paper
• Papel Prognóstico a Muito Longo Prazo do BNP de Admissão na Síndrome Coronariana Aguda sem Elevação do Segmento ST Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome

  2015cites this paper
• Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients

  2015cites this paper
• Identifying biomarker patterns and predictors of inflammation and myocardial stress.

  2015cites this paper
• Clinical value of natriuretic peptides in chronic kidney disease.

  2015cites this paper
• Biomarcadores cardiacos como ayuda diagnóstica en las cardiopatías

  2014cites this paper
• SECTION 2 Organ-Specifi c Function Tests and Drug-Induced Diseases

  2014cites this paper
• [Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease].

  2014cites this paper
• Chronic Heart Failure: The Roles of the Tumor Necrosis Factor-Alpha Axis and Left-Atrial Structural and Functional Remodeling

  2014cites this paper
• Questions and guide to answers (Q&A) in internal medicine: give an account on compartment syndrome, hyperhomocysteinemia, brain natriuretic peptide, and viral autoimmune manifestations

  2014cites this paper
• Características epidemiológicas, clínicas, tratamiento y pronóstico de los pacientes con diagnóstico de síndrome coronario agudo en unidad especializada Epidemiological and clinical characteristics, treatment and prognosis of patients with acute coronary syndrome in a specialized unit

  2014cites this paper
• Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca2+ release, and activation of protein kinase C

  2014influential citation
• N‐terminal pro‐brain natriuretic peptide in the assessment of respiratory distress in term neonates

  2014cites this paper
• Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

  2014cites this paper
• The Prognostic value of N-Terminal-ProBrain Natriuretic Peptide in the Diagnosis and to Detect the Progression of Left Ventricular Mass and Function in Patients with Chronic Kidney Disease

  2014cites this paper
• Diagnostic Values of Plasma, Fresh and Frozen Urine NT-proBNP in Heart Failure Patients

  2014cites this paper
• Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis.

  2014cites this paper
• B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function

  2013cites this paper
• Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform.

  2013cites this paper
• Evaluation of Cirrhotic Cardiomyopathy in Patients with Hepatocellular Carcinoma by Brain Natriuretic Peptide and Echocardiography Before and After Radiofrequency Ablation

  2013cites this paper
• Characteristics of cardiovascular dysfunction and pulmonary hypertension in patients with sickle cell disease

  2013cites this paper
• N-terminal Pro-Brain Natriuretic Peptide and Exercise Capacity in Chronic Heart Failure: Data from the HF-ACTION Study

  2013cites this paper
• An Investigation of Outcomes in Relation to Thiamin Status of Ambulatory Patients with Heart Failure

  2012cites this paper
• Biomarkers as a guide of medical treatment in cardiovascular diseases.

  2012cites this paper
• [Recent advances in natriuretic peptide family genes and cardiovascular diseases].

  2012influential citation
• B-type natriuretic peptide: use and misuse in the older patient

  2012cites this paper
• The use of cardiac biomarkers in veterinary medicine: the equine perspective Diergeneeskundig gebruik van cardiogene biomarkers : focus op het gebruik bij paarden

  2012cites this paper
• Improvement of cardiac function and reversal of gap junction remodeling by Neuregulin-1β in volume-overloaded rats with heart failure

  2012cites this paper
• Outcome of diabetic and non-diabetic patients undergoing successful percutaneous coronary intervention of chronic total occlusion.

  2011cites this paper
• The relationship between the time interval difference of isovolumic relaxation (T[IVRT-IVRTa]) and serum levels of N-terminal pro-brain natriuretic peptide in patients with intermediate E/Ea ratio.

  2011cites this paper
• The Relationship between Serum NT- Pro-BNP Levels and Prognosis in Patients with Systolic Heart Failure.

  2011cites this paper
• Updating the Role of Natriuretic Peptide Levels in Cardiovascular Disease

  2011cites this paper
• The functional genomics of guanylyl cyclase/natriuretic peptide receptor‐A: Perspectives and paradigms

  2011cites this paper
• Biomarkers as surrogate end points in heart failure trials.

  2011cites this paper
• Amino-Terminal Fragment of the Prohormone Brain-type Natriuretic Peptide (NT-proBNP) in Rheumatoid Arthritis

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Clinical relevance of tumor markers and epidemiology of neuroendocrine tumors

  2011cites this paper
• Einfluss der hämodynamischen Belastung auf das myokardiale Remodeling bei Kindern mit Atrium-Septum-Defekt : die Rolle der Apoptose

  2011cites this paper
• Natriuretic Peptide-guided therapy for heart failure.

  2011cites this paper
• Subclinical left ventricular dysfunction in Behcet's disease assessed by two-dimensional speckle tracking echocardiography.

  2011cites this paper
• Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

  2011influential citation
• Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis

  2010influential citation
• Prevalence and pharmacological treatment of left‐ventricular dysfunction in patients undergoing vascular surgery

  2010cites this paper
• [Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure].

  2010cites this paper
• The cellular expression of antiangiogenic factors in fetal primate macula.

  2010cites this paper
• Prognostic Implications of Asymptomatic Left Ventricular Dysfunction in Patients Undergoing Vascular Surgery

  2010cites this paper
• The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.

  2010cites this paper
• Facteur atrial natriurétique

  2010cites this paper
• [Comorbidities in COPD].

  2010cites this paper
• B-type natriuretic peptide and severe heart failure at baseline predict overall mortality in incident dialysis patients.

  2010cites this paper
• B-type natriuretic peptide pretreatment attenuates heart ischemia-reperfusion injury in rats.

  2010cites this paper
• Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels.

  2010cites this paper
• The efficacy of spironolactone in the treatment of acute respiratory distress syndrome-induced rats.

  2010cites this paper
• Apelin attenuates hyperoxic lung and heart injury in neonatal rats.

  2010cites this paper
• Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.

  2010cites this paper
• TEI INDEX OBTAINED FROM TISSUE DOPPLER IMAGING : CORRELATION WITH NTPROBNP LEVELS IN PATIENTS WITH DILATED CARDIOMIOPATHY

  2010cites this paper
• Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.

  2009cites this paper
• Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.

  2009cites this paper